Ditchcarbon
  • Contact
  1. Organizations
  2. Genus
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated a month ago

Genus

Company website

Genus plc, commonly referred to as Genus, is a leading global player in the biotechnology industry, headquartered in Great Britain. Founded in 1938, the company has established itself as a pioneer in animal genetics, focusing on improving livestock productivity and sustainability. With major operations across North America, Europe, and Asia, Genus is dedicated to advancing agricultural practices through innovative breeding solutions. The company offers a range of core products and services, including genetic improvement programmes for cattle and pigs, which are distinguished by their emphasis on health, efficiency, and environmental sustainability. Genus has achieved notable milestones, such as being the first to introduce genomic selection in livestock, solidifying its market position as a trusted partner for farmers worldwide. With a commitment to research and development, Genus continues to lead the way in enhancing food security and animal welfare.

DitchCarbon Score

How does Genus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

49

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Genus's score of 49 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

69%

Let us know if this data was useful to you

Genus's reported carbon emissions

In 2024, Genus reported total carbon emissions of approximately 656,297,940 kg CO2e, comprising 200,000 kg CO2e from Scope 1, 6,732,310 kg CO2e from Scope 2, and a significant 649,297,640 kg CO2e from Scope 3 emissions. This marks a notable increase in emissions compared to 2023, where total emissions were about 569,167,930 kg CO2e, with 321,550 kg CO2e from Scope 1 and 5,691,670 kg CO2e from Scope 2. In the UK, Genus's emissions for 2023 were approximately 3,086,000 kg CO2e for Scope 1 and 2 combined, with Scope 2 emissions alone at 162,000 kg CO2e. The previous year, 2022, saw Scope 2 emissions of about 150,000 kg CO2e, indicating a slight increase in emissions over the year. Despite these figures, Genus has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or SBTi commitments. The company’s emissions data is not cascaded from a parent organization, ensuring that the reported figures are solely reflective of Genus's operations. Overall, Genus's emissions profile highlights the significant impact of Scope 3 emissions, which dominate their total carbon footprint, underscoring the need for comprehensive strategies to address emissions across all scopes.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
-
00,000,000
00,000,000
00,000,000
00,000,000
000,000
000,000
Scope 2
8,398,000
0,000,000
0,000,000
0,000,000
00,000,000
0,000,000
0,000,000
Scope 3
-
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genus's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genus is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Genus is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

BASF SE

DE
•
Chemicals nec
Updated 3 days ago

Alltech

US
•
Research and development services (73)
Updated 3 days ago

Zoetis

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Cegelec SAS

FR
•
Electrical machinery and apparatus n.e.c. (31)
Updated 18 days ago

Heska Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

Merial S.A.S.

FR
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy